RenoFi | $22,000,000 | (Mar 4, 2026)
Worldscape | Undisclosed Amount | (Mar 4, 2026)
MightyFly | $10,000,000 | (Mar 4, 2026)
Certified by Founder
Lodge
Dispatch Bio
start up
- 24/07/2025
- Series A
- Undisclosed Amount
Established in 2022, Dispatch Bio was founded with a bold purpose: to help create a world where all cancer patients can be cured. To achieve this, the company is engineering a universal treatment across solid tumors, leveraging its first-in-class Flare platform. This novel approach combines the strengths of immunotherapy with a tumor-specific viral vector, both engineered to clear tumor cells with precision and power. Dispatch has operations in Philadelphia and San Francisco, with access to world-class researchers.
- Industry Biotechnology Research
- Website https://dispatchbio.com/
- LinkedIn https://www.linkedin.com/company/dispatch-bio/
Qura | $1,739,595 | (Mar 4, 2026)
KeyCare | $27,400,000 | (Mar 4, 2026)
Devotion(US) | $4,000,000 | (Mar 4, 2026)
Burst | $2,100,000 | (Mar 4, 2026)
JetStream Security Inc. | $34,000,000 | (Mar 4, 2026)
Escargot | $2,750,000 | (Mar 4, 2026)
EGI Battery | $10,000,000 | (Mar 4, 2026)
Bindbridge | $3,800,000 | (Mar 4, 2026)
Inhouse | $5,000,000 | (Mar 3, 2026)